SOD2 and breast carcinoma: To that regards, we have provided evidence to link increased MnSOD expression with the aggressive basal‐like breast cancer subtype, and underscored the judicious use of PPARγ ligands for specifically downregulating MnSOD to overcome the chemo‐resistance in this subtype of breast cancer.